Mood Disorders
Mood disorders, including depression and bipolar disorder, are characterized by extreme mood states that are not controllable and which interfere with daily living. Depressed persons may feel sad, distressed, and hopeless even though there is no reason for them to feel that way. People with bipolar disorder may experience abnormally high energy and an elevated sense of mood and self that interferes with their ability to make reasonable choices. Mood disorders are common and treatable medical illnesses.
Please review the links below to learn more about the treatments for Mood Disorders that are offered at the Penn Comprehensive Neuroscience Center.
Center for Cognitive Therapy
The Center for Cognitive Therapy provides an active, directive, problem-focused outpatient therapy for a variety of clinical concerns, including mood disorders, anxiety and panic, life stressors, couple and family discord, and many other issues. Treatment is based on cognitive behavioral therapy model.
Mood Disorders Comprehensive Consultation
Service
The Comprehensive Consultation Service
(CCS) provides comprehensive,
state-of-the-art assessments and second opinions
for individuals with mood and anxiety disorders,
including: bipolar disorder, major depression,
dysthymia, mood disorders secondary to medical
conditions and anxiety disorders.
Outpatient Psychiatry Center
The Outpatient Psychiatry Center (OPC) of the
Penn Department of Psychiatry offers comprehensive
psychiatric services, including diagnostic evaluations,
psychotherapy service, medication management,
group and couples therapy.
Behavioral
Health Outpatient Center
The Behavioral
Health Outpatient Center at Pennsylvania Hospital
can provide a fresh perspective and offer practical
approaches to better enable individuals or those
they care about to take control of situations
which have had a negative impact on their lives.
Clinical Research Options
In addition to the programs listed above, Penn also offers patient care programs that require patients to be enrolled in a clinical trial. Patients who are eligible to participate in research can receive treatment at no cost.
To learn more about clinical research options select a link below:
Bipolar Research Program
Our outpatient treatment program offers state-of-the-art outpatient treatment for eligible individual's ages 18 and older suffering from bipolar disorders. The program is part of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), a national treatment monitoring study designed to improve understanding of how various medications and combinations of medication work in real life settings.
Depression Research Unit
Diagnosis and treatment of affective disorders (depression and manic depression), with an emphasis on pharmacological treatment approaches, are offered. Research on the development and use of new and conventional antidepressant medications, including lithium carbonate, is ongoing. Other areas of specialized investigation include treatment-resistant depression and the interaction of hormones and mood.
Mood and Anxiety Disorders Program
The Mood and Anxiety Disorders Program has gained an international reputation over the past 30 years for its high caliber of research. Our researchers specialize in studying the causes of, and latest treatments for, mood and anxiety disorders. We are continually working on new medication treatment programs that will help people cope with mental health problems that could otherwise be debilitating.
Center for Psychotherapy Research
The Center for Psychotherapy Research offers free psychotherapeutic treatment and/or medication in exchange for participation in studies of depression, generalized anxiety panic disorder, and cocaine dependance . All treatments are free of charge and provided by University of Pennsylvania faculty and staff, if one meets inclusion criteria to study.
rTMS for Depression in Pregnancy Study
This study aims to examine an investigational magnetic device in women with depression (major depressive disorder) during pregnancy. There will be phone screen followed by an initial visit with the Principal Investigator (Dr. Kim). If the subject qualifies and is enrolled in the study, treatment will consist of 4 weeks of 10 minute treatment sessions. There will be an additional 10 minutes of screening tools administered. Blood work will be checked twice. Fetal ultrasounds and fetal monitoring will be done 2–3 times throughout the study. Treatment is free but there is no reimbursement for participating. Subjects will be followed until 6 weeks postpartum.
Resources
|
